VF
MTNB icon

Virtu Financial’s Matinas BioPharma MTNB Stock Holding History

Virtu Financial’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,569
Closed -$9K – 2054
2025
Q4 		$9K Buy
+15,569
New +$18.3K ﹤0.01% 1520
2024
Q3 		– Sell
-817
Closed -$6K – 1698
2024
Q2 		$6K Buy
+817
New +$7.41K ﹤0.01% 1174
2024
Q1 		– Sell
-3,258
Closed -$35K – 1838
2023
Q4 		$35K Buy
+3,258
New +$36.8K ﹤0.01% 1230
2023
Q3 		– Sell
-1,806
Closed -$33K – 1668
2023
Q2 		$33K Buy
+1,806
New +$42.1K ﹤0.01% 1187
2023
Q1 		– Sell
-2,882
Closed -$72K – 1869
2022
Q4 		$72K Buy
2,882
+2,357
+449% +$78.4K 0.01% 1020
2022
Q3 		$17K Sell
525
-1,314
-71% -$51.6K ﹤0.01% 1434
2022
Q2 		$73K Buy
+1,839
New +$70.1K 0.01% 1011
2022
Q1 		– Sell
-1,694
Closed -$86K – 1828
2021
Q4 		$86K Sell
1,694
-2,923
-63% -$156K 0.01% 1187
2021
Q3 		$300K Buy
+4,617
New +$199K 0.03% 714
2021
Q1 		– Sell
-941
Closed -$64K – 1873
2020
Q4 		$64K Buy
+941
New +$43.6K 0.01% 1181
2019
Q4 		$333K Buy
+2,935
New +$170K 0.03% 620
2019
Q3 		– Sell
-594
Closed -$25K – 1686
2019
Q2 		$25K Sell
594
-1,739
-75% -$83.6K ﹤0.01% 1318
2019
Q1 		$127K Buy
2,333
+1,037
+80% +$55.9K 0.01% 1093
2018
Q4 		$39K Buy
+1,296
New +$50.9K ﹤0.01% 1303
2018
Q1 		– Sell
-2,123
Closed -$123K – 2358
2017
Q4 		$123K Buy
2,123
+1,184
+126% +$76.1K 0.01% 1851
2017
Q3 		$62K Buy
+939
New +$62.7K ﹤0.01% 2193

Other funds holding MTNB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HIW
Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial's MTNB Position: Q1 2026 in Review

Virtu Financial sold out of Matinas BioPharma (MTNB) in Q1 2026, closing a stake of 15,569 shares — an estimated $9K sold.

Virtu Financial first reported a position in MTNB in Q3 2017 and held it in 16 quarters. The position peaked at $333K in Q4 2019. 28 funds tracked by Wall St. Rank hold MTNB as of Q1 2026.

  • Virtu Financial reported no remaining Matinas BioPharma position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 15,569 Matinas BioPharma shares in Q1 2026, an estimated $9K.
  • Virtu Financial first reported a position in Matinas BioPharma in Q3 2017 and held it in 16 quarters.
  • Virtu Financial's Matinas BioPharma position peaked at $333K in Q4 2019.
  • 28 funds tracked by Wall St. Rank held Matinas BioPharma as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.